Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
Condition(s):Diabetes Mellitus, Type 1Last Updated:March 2, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus, Type 1Last Updated:March 2, 2023Completed
Condition(s):Type 1 DiabetesLast Updated:June 18, 2023Enrolling by invitation
Condition(s):Type1diabetes; Fatty LiverLast Updated:July 6, 2023Enrolling by invitation
Condition(s):Diabetes Mellitus, Type 1; Diabetes; Type 1 Diabetes; Diabetes MellitusLast Updated:May 8, 2023Recruiting
Condition(s):Type1 Diabetes MellitusLast Updated:March 29, 2022Completed
Condition(s):Type 1 Diabetes MellitusLast Updated:January 11, 2021Completed
Condition(s):Type 1 DiabetesLast Updated:March 27, 2024Recruiting
Condition(s):Diabetes Mellitus, Type 1Last Updated:May 17, 2022Completed
Condition(s):NAFLD; Type 1 Diabetes; Cardiovascular DiseasesLast Updated:March 4, 2022Recruiting
Condition(s):Type1 Diabetes MellitusLast Updated:January 18, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.